Caruso S, et al. - Researchers here evaluated the effects of a 20 mcg Ethinylestradiol (EE) and 3 mg Drospirenone (DRSP) oral contraceptive (20mcgEE/3mgDRSP) in a continuous regimen, associated with rehabilitation therapy on Meniere's disease. Outcomes suggested DRSP as efficacious in reducing the fluid overload typical of the premenstrual phase, improving symptoms of MD. Results thereby supported the efficacy of EE/DRSP usage associated with rehabilitation therapy on premenstrual exacerbation of MD.